Healthcare

Key Players in the Peptide Therapeutics CDMO Market: Company Profiles

Companies, Healthcare
/ / ,

Peptide Therapeutics CDMO Market Companies Almac Group AmbioPharm Inc. American Peptide Company Auspep Pty Ltd. Bachem AG BCN Peptides S.A. Chinese Peptide Company (CPC) CordenPharma International CPC Scientific Inc. Creative Peptides CSBio Co. GenScript Biotech Corporation Lonza Group Ltd. Peptide Institute Inc. Piramal Pharma Solutions PolyPeptide Group Sanofi (Zentiva) ScinoPharm Taiwan Ltd. Siegfried Holding AG […]

Leading AI-Integrated CDMO Process Optimization Market Companies: A Detailed Profile

Companies, Healthcare
/ / ,

AI-Integrated CDMO Process Optimization Market Companies Lonza Group Ltd. Catalent Inc. Thermo Fisher Scientific Inc. LabCorp Drug Development IQVIA Technologies WuXi AppTec Co. Ltd. Boehringer Ingelheim Samsung Biologics Recipharm AB Patheon (part of Thermo Fisher) Evonik Industries AG Siegfried Holding AG Aenova Group Cambrex Corporation Albany Molecular Research Inc. (AMRI) Piramal Pharma Solutions Metrics Contract

Health Information Exchange (HIE) Market Companies: Detailed Profiles & Analysis

Companies, Healthcare
/

Health Information Exchange (HIE) Market Companies Cerner Corporation Allscripts Healthcare Solutions, Inc. McKesson Corporation GE Healthcare Meditech eClinicalWorks NextGen Healthcare Orion Health InterSystems Corporation Optum, Inc. IBM Corporation Siemens Healthineers Athenahealth, Inc. Health Catalyst, Inc. CPSI Oracle Corporation Infor Philips Healthcare HealthFusion SAP SE Get Sample Report Cerner Corporation (Acquired by Oracle) Company Name and Headquarters: Cerner

Smart Retinal Implants Market Restore vision with wireless bioelectronic prosthetics and AI-powered retinal technologies

Healthcare
/ /

The global smart retinal implants market is poised for robust expansion from 2025 to 2034, driven by increasing prevalence of vision-impairing diseases, rapid technological advancements in retinal prosthetics, and wider adoption of AI-enabled vision restoration systems. Valued at growing billions today, the market offers new hope for patients suffering from degenerative retinal conditions like age-related

RNA Editing for Neurodegenerative Diseases Market: Key Company Profiles

Companies, Healthcare
/ / ,

RNA Editing for Neurodegenerative Diseases Market Companies ADARx Pharmaceuticals Amber Bio Ascidian Therapeutics Beam Therapeutics Eli Lilly & Co. GSK Plc Korro Bio Moderna Inc. ProQR Therapeutics Roche Holding AG Shape Therapeutics Takeda Pharmaceutical Company Verve Therapeutics Wave Life Sciences Regeneron Pharmaceuticals Download Sample Report ADARx Pharmaceuticals Company Name and Headquarters: ADARx Pharmaceuticals, Inc. – San

The Leading AI-Driven Drug Discovery Platforms Market Companies: A Detailed Profile

Companies, Healthcare
/ / ,

AI-Driven Drug Discovery Platforms Market Companies Atomwise BenevolentAI Cloud Pharmaceuticals DeepMind (Alphabet) Exscientia Healx Insilico Medicine LabGenius Numerate Owkin Recursion Pharmaceuticals Relay Therapeutics Schrödinger Valo Health twoXa Download Sample Report Atomwise Company Name and Headquarters: Atomwise Inc., San Francisco, CA, USA Product Offerings: AtomNet® platform, an AI-powered drug discovery platform that uses deep convolutional neural networks to

Key Players in the Rare Musculoskeletal Disorder Treatments Market: A Comprehensive Company Profile

Companies, Healthcare
/ / ,

Rare Musculoskeletal Disorder Treatments Market Companies Astellas Amgen AstraZeneca BioMarin Pharmaceutical Eli Lilly Fujifilm/possible CDMOs (manufacturing partners) Ionis Pharmaceuticals Novartis Pfizer PTC Therapeutics Regenxbio Sarepta Therapeutics Sanofi Takeda Cytokinetics Download Sample Report Astellas Pharma Inc. Headquarters: Tokyo, Japan Product Offerings related to Rare Musculoskeletal Disorder Treatments: While Astellas is a major pharmaceutical company with a broad portfolio,

RNA Editing Therapies Market: Key Companies and Their Strategic Landscape Meta Title:

Companies, Healthcare
/ / ,

RNA Editing Therapies Market Companies ADARx Pharmaceuticals Amber Bio Ascidian Therapeutics Beam Therapeutics Catalent GSK Korro Bio Moderna ProQR Therapeutics Regenxbio Roche Shape Therapeutics Wave Life Sciences ADAPTABLE CDMO / specialized oligo CDMOs Smaller specialist startups & platform players Download Sample Report ADARx Pharmaceuticals Company Name and Headquarters: ADARx Pharmaceuticals, Inc. (San Diego, California, USA) Product

Rare Disease Small-Batch CDMO Market Accelerate orphan drug production with flexible manufacturing and tailored CDMO partnerships

Healthcare
/ /

The rare disease small-batch CDMO market is projected to experience significant growth through 2034, driven by the increasing prevalence of rare diseases and the rising approvals of orphan drugs. With an expected compound annual growth rate (CAGR) propelled by advancements in precision medicine and specialized manufacturing, this market is becoming a critical partner for biopharma

Scroll to Top